Science & Technology
Induce Biologics Inc.
Science & Technology PDF Print E-mail

The pre-clinical proof-of-principle work to advance URIST™ into clinical development has been completed and the processes required to manufacture the BMP and URIST™ have been developed. Animal studies have demonstrated the ability of URIST™ to generate more bone, of higher quality, than the currently approved BMP product, using less BMP.

 

 

 

 

 

 

 

 

 

 

 

 

Market Opportunity: The orthobiologics market (which is the use of biological approaches to regenerate and repair tissue) is estimated to be a US $4.4 billion market, with an expected annual growth of 5%. BMP-based products are one of the largest segments of this market.

 

News

Follow InduceBio on Twitter and get all the updates regarding our latest activities, products, and future plans.

Follow Us on Twitter